Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1243, 2000-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bivalirudin preferable in coronary angioplasty?
Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. :
Access to resources
Recommend
Extra cost of abciximab justified in PCI?
Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. :
Abciximab + stenting worth its cost?
Inpharma, Vol. 1, Iss. 1306, 2001-01 ,pp. :
Abciximab + stenting worth its cost?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 331, 2001-01 ,pp. :
Extra cost of abciximab justified in PCI?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 313, 2001-01 ,pp. :